The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model

Erik R. Sampson(University of Rochester Medical Center), Randy N. Rosier(University of Rochester Medical Center)
Journal of Bone and Mineral Research
February 1, 2011
10.1002/jbmr.336
Cited by 49

Related Papers

No related papers found

Powered by citation graph analysis